<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="eb-pa" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">eb-pa</book-part-id>
      <title-group>
        <title>Epidermolysis Bullosa with Pyloric Atresia</title>
        <alt-title alt-title-type="alt-title">Synonyms: Carmi Syndrome, EB-PA, Junctional Epidermolysis Bullosa with Pyloric Atresia, PA-JEB</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pfendner</surname>
            <given-names>Ellen G</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Director, EBDx Program <break/>GeneDx, Inc <break/>Gaithersburg, Maryland</aff>
          <email>ellen@genedx.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lucky</surname>
            <given-names>Anne W</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Director, Cincinnati Children's Epidermolysis Bullosa Center <break/>Cincinnati Children's Hospital <break/>Cincinnati, Ohio</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>22</day>
          <month>2</month>
          <year>2008</year>
        </date>
        <date date-type="updated">
          <day>7</day>
          <month>9</month>
          <year>2017</year>
        </date>
        <date date-type="revised">
          <day>28</day>
          <month>4</month>
          <year>2009</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="ebs" document-type="chapter">Epidermolysis Bullosa Simplex</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="gale-def" document-type="chapter">Epimerase Deficiency Galactosemia</related-object>
      <abstract id="eb-pa.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Epidermolysis bullosa with pyloric atresia (EB-PA) is characterized by fragility of the skin and mucous membranes, manifested by blistering with little or no trauma; congenital pyloric atresia; and ureteral and renal anomalies (dysplastic/multicystic kidney, hydronephrosis/hydroureter, ureterocele, duplicated renal collecting system, absent bladder). The course of EB-PA is usually severe and often lethal in the neonatal period. Most affected children succumb as neonates; those who survive may have severe blistering with formation of granulation tissue on the skin around the mouth, nose, fingers, and toes, and internally around the trachea. However, some affected individuals have little or no blistering later in life. Additional features shared by EB-PA and the other major forms of EB include congenital localized absence of skin (aplasia cutis congenita) affecting the extremities and/or head, milia, nail dystrophy, scarring alopecia, hypotrichosis, contractures, and dilated cardiomyopathy.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of EB-PA is established in a proband with characteristic clinical findings by molecular genetic testing that identifies biallelic pathogenic variants in one of the genes associated with EB-PA: <italic toggle="yes">ITGA6</italic> (~5% of EB-PA), <italic toggle="yes">ITGB4</italic> (~80%), or <italic toggle="yes">PLEC</italic> (~15%). Skin biopsy using transmission electron microscopy (TEM) and/or immunofluorescent antibody/antigen mapping can be performed but is no longer the preferred method of diagnosis.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Lance and drain new blisters and dress with three layers (primary: nonadherent; secondary: for stability and protection; tertiary: elastic properties to insure integrity); protect skin from shearing forces; teach caretakers proper handling of infants and children; surgical intervention to correct pyloric atresia; standard treatment for gastroesophageal reflux disease; nutrition consultation to address oral intake and nutritional needs; referral to urology and/or nephrology for renal anomalies and abnormal renal function; tracheostomy when indicated for respiratory failure; psychosocial support, including social services and psychological counseling.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Minimization of new blister formation by wrapping and padding of extremities, use of soft and properly fitted clothing and footwear, avoidance of contact with adhesives and of contact sports and other activities that create friction.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Antibiotics and antiseptics to prevent wound infections; attention to fluid and electrolyte balance; additional nutritional support including a feeding gastrostomy when necessary; calcium, vitamin D, zinc, selenium, carnitine, and iron supplements as indicated.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual screening for anemia and zinc, vitamin D, and other nutritional deficiencies; periodic echocardiographic screening for dilated cardiomyopathy; bone mineral density scanning for detection of osteopenia and/or osteoporosis.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Shearing forces on the skin; ordinary medical tape or Band-Aids<sup>&#x000ae;</sup>; poorly fitting or coarse-textured clothing and footwear.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> Consider cesarean section to reduce trauma to the skin of an affected fetus during delivery.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>EB-PA is inherited in an autosomal recessive manner. The parents of an affected child are usually obligate heterozygotes (i.e., carriers). Because germline mosaicism and uniparental isodisomy are possible, carrier status of parents needs to be confirmed with molecular genetic testing. At conception, each sib of an affected individual whose parents are both carriers has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for family members at increased risk and prenatal diagnosis or preimplantation genetic diagnosis for pregnancies at increased risk are possible if both pathogenic variants have been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="eb-pa.Diagnosis">
        <title>Diagnosis</title>
        <sec id="eb-pa.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Epidermolysis bullosa with pyloric atresia (EB-PA) <bold>should be suspected</bold> in newborns with the following clinical features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Congenital pyloric atresia with vomiting and abdominal distension resulting from complete obstruction of the gastric outlet. Radiographs reveal that the stomach is distended and filled with air (see <xref ref-type="fig" rid="eb-pa.F1">Figure 1</xref>).</p>
            </list-item>
            <list-item>
              <p>Fragility of the skin with:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Blistering with little or no trauma. Blistering may be mild or severe; however, blisters generally heal with no significant scarring.</p>
                </list-item>
                <list-item>
                  <p>Significant oral and mucous membrane involvement</p>
                </list-item>
                <list-item>
                  <p>Large areas of absent skin (aplasia cutis congenital), often with a thin membranous covering, affecting the extremities or head</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Ureteral and renal anomalies, including hydronephrosis, ureterocele, absent bladder, dysplastic kidneys, urinary collecting system/kidney duplication, obstructive uropathy, and glomerulosclerosis</p>
            </list-item>
          </list>
        </sec>
        <sec id="eb-pa.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of EB-PA <bold>is established</bold> in a proband by one or both of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Identification of biallelic pathogenic variants in a gene associated with EB-PA using molecular genetic testing (<xref ref-type="table" rid="eb-pa.T.molecular_genetic_testing_used_i">Table 1</xref>)</p>
            </list-item>
            <list-item>
              <p>Skin biopsy using transmission electron microscopy (TEM) and/or immunofluorescent antibody/antigen mapping (see <xref ref-type="sec" rid="eb-pa.Skin_Biopsy">Skin Biopsy</xref>)</p>
            </list-item>
          </list>
          <p>Note: Genetic testing is the preferred diagnostic method. Skin biopsy for diagnostic purposes is no longer routinely performed</p>
          <sec id="eb-pa.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p>Molecular testing approaches can include use of a <bold>multi-gene panel</bold>, <bold>more comprehensive</bold>
<bold>genomic testing</bold>, and <bold>serial single-gene testing</bold>.</p>
            <p><bold>A multi-gene panel</bold> (including phenotype-focused exome analysis) that includes <italic toggle="yes">ITGA6, ITGB4</italic>, <italic toggle="yes">PLEC</italic>, and other genes of interest (see <xref ref-type="sec" rid="eb-pa.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included and the sensitivity of multi-gene panels vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
            <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            <p><bold>More comprehensive genomic testing</bold> including exome sequencing and genome sequencing may also be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            <p>
              <bold>Serial single-gene testing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Sequence analysis of <italic toggle="yes">ITGB4</italic> may be performed first, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
              </list-item>
              <list-item>
                <p>If only one no or pathogenic variant in <italic toggle="yes">ITGB4</italic> is identified, sequence analysis of <italic toggle="yes">PLEC</italic> followed by <italic toggle="yes">ITGA6</italic> (if only one or no pathogenic variant in <italic toggle="yes">PLEC</italic> is identified) may be considered next.</p>
              </list-item>
            </list>
            <table-wrap id="eb-pa.T.molecular_genetic_testing_used_i" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Molecular Genetic Testing Used in Epidermolysis Bullosa with Pyloric Atresia</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_2">Proportion of EP-BA Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by Test Method</th>
                  </tr>
                  <tr>
                    <th headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3" id="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>4</sup></th>
                    <th headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3" id="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">ITGA6</italic>
                    </td>
                    <td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">5%</td>
                    <td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">5%</td>
                    <td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">ITGB4</italic>
                    </td>
                    <td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">60%</td>
                    <td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">~98%&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Rare&#x000a0;<sup>7</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">PLEC</italic>
                    </td>
                    <td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15%</td>
                    <td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">15%</td>
                    <td headers="hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_eb-pa.T.molecular_genetic_testing_used_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="eb-pa.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="eb-pa" object-id="eb-pa.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="eb-pa.TF.1.2">
                  <label>2. </label>
                  <p>
                    <xref ref-type="bibr" rid="eb-pa.REF.varki.2006.641">Varki et al [2006]</xref>
                  </p>
                </fn>
                <fn id="eb-pa.TF.1.3">
                  <label>3. </label>
                  <p>See <xref ref-type="sec" rid="eb-pa.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="eb-pa.TF.1.4">
                  <label>4. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="eb-pa.TF.1.5">
                  <label>5. </label>
                  <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
                </fn>
                <fn id="eb-pa.TF.1.6">
                  <label>6. </label>
                  <p>50% of persons of Hispanic heritage in the United States have the <italic toggle="yes">ITGB4</italic> pathogenic variant <xref ref-type="table" rid="eb-pa.T.selected_itgb4_pathogenic_varian">p.Cys61Tyr</xref> [<xref ref-type="bibr" rid="eb-pa.REF.varki.2006.641">Varki et al 2006</xref>].</p>
                </fn>
                <fn id="eb-pa.TF.1.7">
                  <label>7. </label>
                  <p><xref ref-type="bibr" rid="eb-pa.REF.birnbaum.2008.1063">Birnbaum et al [2008]</xref>, <xref ref-type="bibr" rid="eb-pa.REF.menc_a.2016.269">Menc&#x000ed;a et al [2016]</xref></p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec id="eb-pa.Skin_Biopsy">
            <title>Skin Biopsy</title>
            <p>Examination of a skin biopsy by (1) transmission electron microscopy (TEM) and/or (2) immunofluorescent antibody/antigen mapping is sometimes performed to establish the diagnosis of EB-PA</p>
            <p>A punch biopsy that includes the full basement membrane zone is preferred. The biopsy should be taken from the leading edge of a fresh (&#x0003c;12 hours old) blister or from a mechanically induced blister (with a pencil eraser rubbed on the skin). (Older blisters undergo change that may obscure the diagnostic morphology).</p>
            <p>Note:</p>
            <list list-type="bullet">
              <list-item>
                <p>
                  <bold>For TEM</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Specimens must be placed in special fixation medium (e.g., gluteraldehyde) as designated by the laboratory performing the test.</p>
                  </list-item>
                  <list-item>
                    <p>Formaldehyde-fixed samples cannot be used for electron microscopy.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p>
                  <bold>For immunofluorescent antibody/antigen mapping</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Specimens should be sent in sterile carrying medium (e.g., Michel's or Zeus&#x02019;) as specified by the laboratory performing the test.</p>
                  </list-item>
                  <list-item>
                    <p>Some laboratories prefer flash-frozen tissue.</p>
                  </list-item>
                  <list-item>
                    <p>In some laboratories the mapping only designates the level of the cleavage by using various marker antibodies of different layers of the basement membrane. A laboratory that has the antigens for the proteins of interest in EB is preferred because both the level of cleavage and the presence or absence of the specific gene products mutated in EB can be assessed.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold>Light microscopy</bold> is inadequate and unacceptable for the accurate diagnosis of any subtypes of EB.</p>
              </list-item>
            </list>
            <p><bold>Transmission electron microscopy (TEM)</bold> is used to examine the number and morphology of the basement membrane zone structures &#x02013; in particular: the number and morphology of anchoring fibrils; the presence of and morphology of hemidesmosomes, anchoring filaments, and keratin intermediate filaments; and the presence of micro-vesicles showing the tissue cleavage plane.</p>
            <p>Findings on TEM in EB-PA include the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Cleavage may be within the lamina lucida or just above the hemidesmosomes in the lowest layer of the basal keratinocytes.</p>
              </list-item>
              <list-item>
                <p>Hemidesmosomes may be reduced in number or dysmorphic [<xref ref-type="bibr" rid="eb-pa.REF.kunz.2000.376">Kunz et al 2000</xref>, <xref ref-type="bibr" rid="eb-pa.REF.jonkman.2002.1275">Jonkman et al 2002</xref>, <xref ref-type="bibr" rid="eb-pa.REF.charlesworth.2003.1344">Charlesworth et al 2003</xref>, <xref ref-type="bibr" rid="eb-pa.REF.pasmooij.2004.669">Pasmooij et al 2004</xref>].</p>
              </list-item>
            </list>
            <p><bold>Immunofluorescent antibody/antigen mapping.</bold> Findings include the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Abnormal or absent staining with antibodies to &#x003b1;6&#x003b2;4 integrin in EB-PA and other rare forms of junctional epidermolysis bullosa (JEB) as a result of pathogenic variants in either <italic toggle="yes">ITGA6</italic> or <italic toggle="yes">ITGB4</italic></p>
              </list-item>
              <list-item>
                <p>Abnormal or absent staining with antibodies to plectin in EB-PA as a result of <italic toggle="yes">PLEC</italic> pathogenic variants</p>
              </list-item>
            </list>
            <p>Normal staining for other antigens (e.g., collagen VII, laminin 332, keratins 5 and 14) confirms the diagnosis of EB-PA.</p>
            <p>Note: Especially in milder forms of EB, indirect immunofluorescent studies are often not sufficient to make the diagnosis because near-normal antigen levels are detected and no cleavage plane is observed. In addition, absence of one hemidesmosomal component (e.g., ITGA6 or ITGB4) may reduce the staining of other hemidesmosomal components as well (e.g., PLEC, COL17). In these cases electron microscopic examination of a skin biopsy must be performed.</p>
          </sec>
        </sec>
      </sec>
      <sec id="eb-pa.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="eb-pa.Clinical_Description">
          <title>Clinical Description</title>
          <p>The course of epidermolysis bullosa with pyloric atresia (EB-PA) is usually severe and often lethal in the neonatal period. Most affected children succumb as neonates.</p>
          <p><bold>Cutaneous manifestations.</bold> Those who survive the neonatal period may have severe blistering with formation of granulation tissue on the skin around the mouth, nose, fingers, and toes, and internally around the trachea. However, some affected individuals have little or no blistering later in life. Many of the findings listed below are present in multiple forms of EB and are not diagnostic of EB-PA.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Congenital localized absence of skin (aplasia cutis congenita)</bold> can be seen in any of the major types of EB and is not a discriminating diagnostic feature of any of these types of EB. Infants with extensive aplasia cutis congenita and blistering or erosions may have fatal infections with sepsis and severe electrolyte imbalance in the first weeks to months of life.</p>
            </list-item>
            <list-item>
              <p><bold>Milia</bold> are small white-topped papules; they are often confused with epidermal cysts.</p>
            </list-item>
            <list-item>
              <p><bold>Nail dystrophy</bold> is defined as changes in size, color, shape, or texture of nails.</p>
            </list-item>
            <list-item>
              <p><bold>Scarring alopecia</bold> is defined as complete loss of scalp hair follicles as a result of scarring and loss of hair follicles.</p>
            </list-item>
            <list-item>
              <p><bold>Hypotrichosis</bold> is defined as reduction in the number of hair follicles in a given area compared to the number of hair follicles in the same area of a normal individual of the same gender.</p>
            </list-item>
            <list-item>
              <p><bold>Exuberant granulation tissue</bold> does not usually appear until the affected child is a few years old and most children with EB-PA do not survive that long.</p>
            </list-item>
            <list-item>
              <p><bold>Contractures</bold> may result from loss of mobility of joints as a result of fibrous tissue scars.</p>
            </list-item>
          </list>
          <p><bold>Pyloric atresia</bold> may be detected in utero using ultrasound or MRI (see Genetic Counseling, <xref ref-type="sec" rid="eb-pa.Prenatal_Testing_and_Preimplantati">Prenatal Testing and Preimplantation Genetic Diagnosis</xref>). Pyloric atresia is evident at birth. It is characterized by vomiting, failure to tolerate any feeding or to pass stool, and a distended abdomen with a large stomach bubble (see <xref ref-type="fig" rid="eb-pa.F1">Figure 1</xref>). Surgical repair of the pyloric atresia is necessary for survival.</p>
          <p><bold>Renal and ureteral anomalies</bold> can include dysplastic/multicystic kidney, hydronephrosis/hydroureter, acute renal tubular necrosis, obstructive uropathy, ureterocele, duplicated renal collecting system, and absent bladder [<xref ref-type="bibr" rid="eb-pa.REF.puvabanditsin.1997.359">Puvabanditsin et al 1997</xref>, <xref ref-type="bibr" rid="eb-pa.REF.kambham.2000.190">Kambham et al 2000</xref>, <xref ref-type="bibr" rid="eb-pa.REF.nakano.2000.493">Nakano et al 2000</xref>, <xref ref-type="bibr" rid="eb-pa.REF.wallerstein.2000.286">Wallerstein et al 2000</xref>, <xref ref-type="bibr" rid="eb-pa.REF.varki.2006.641">Varki et al 2006</xref>, <xref ref-type="bibr" rid="eb-pa.REF.pfendner.2007.781">Pfendner et al 2007</xref>, <xref ref-type="bibr" rid="eb-pa.REF.walker.2017.e61">Walker et al 2017</xref>].</p>
        </sec>
        <sec id="eb-pa.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>The forms of EB-PA with the severest cutaneous manifestations are caused by a pathogenic variant on each allele that results in a premature termination codon, although a number of amino acid substitutions also result in a severe phenotype, such as the recurrent <italic toggle="yes">ITGB4</italic> variant <xref ref-type="table" rid="eb-pa.T.selected_itgb4_pathogenic_varian">p.Cys61Tyr</xref>, which is common in Hispanic individuals with EB-PA [<xref ref-type="bibr" rid="eb-pa.REF.varki.2006.641">Varki et al 2006</xref>, <xref ref-type="bibr" rid="eb-pa.REF.masunaga.2015.61">Masunaga et al 2015</xref>, <xref ref-type="bibr" rid="eb-pa.REF.mutlu.2015.385">Mutlu et al 2015</xref>, <xref ref-type="bibr" rid="eb-pa.REF.menc_a.2016.269">Menc&#x000ed;a et al 2016</xref>, <xref ref-type="bibr" rid="eb-pa.REF.masunaga.2017.160">Masunaga et al 2017</xref>].</p>
        </sec>
        <sec id="eb-pa.Penetrance">
          <title>Penetrance</title>
          <p>Pathogenic variants in <italic toggle="yes">ITGA6</italic>, <italic toggle="yes">ITGB4</italic>, and <italic toggle="yes">PLEC</italic> are 100% penetrant in individuals who have biallelic pathogenic variants in the same gene.</p>
        </sec>
        <sec id="eb-pa.Prevalence">
          <title>Prevalence</title>
          <p>According to the National EB Registry, prevalence of all types of junctional epidermolysis bullosa (JEB) is 0.44 per million in the US population [<xref ref-type="bibr" rid="eb-pa.REF.fine.1999">Fine et al 1999</xref>]. Historically, EB-PA was considered a subclass of junctional EB (JEB); however, EB-PA is rare and its prevalence and incidence have not been determined.</p>
          <p>Since EB-PA is extremely rare, carrier frequency in the general population is not known; however, it can be conservatively estimated at less than one in 5000 (~10x rarer than Herlitz junctional epidermolysis bullosa [HJEB], the carrier frequency of which is ~1:700).</p>
        </sec>
      </sec>
      <sec id="eb-pa.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">ITGA6</italic>.</bold> EB-PA is the only phenotype associated with pathogenic variants in <italic toggle="yes">ITGA6</italic>.</p>
        <p><bold><italic toggle="yes">ITGB4</italic>.</bold> Biallelic pathogenic variants in <italic toggle="yes">ITGB4</italic> rarely cause <related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter">epidermolysis bullosa simplex</related-object> (EBS), <related-object link-type="booklink" source-id="gene" document-id="ebj" document-type="chapter">junctional epidermolysis bullosa</related-object> (JEB) [<xref ref-type="bibr" rid="eb-pa.REF.inoue.2000.1061">Inoue et al 2000</xref>, <xref ref-type="bibr" rid="eb-pa.REF.jonkman.2000.227">Jonkman et al 2000</xref>], or pyloric atresia with desquamative enteropathy and no skin disease [<xref ref-type="bibr" rid="eb-pa.REF.salvestrini.2008.585">Salvestrini et al 2008</xref>].</p>
        <p><bold><italic toggle="yes">PLEC</italic>.</bold> The other phenotypes associated with <italic toggle="yes">PLEC</italic> pathogenic variants:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>EB with muscular dystrophy (EB-MD)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/226670">226670</ext-link>) [<xref ref-type="bibr" rid="eb-pa.REF.charlesworth.2003.1344">Charlesworth et al 2003</xref>, <xref ref-type="bibr" rid="eb-pa.REF.kossharnes.2004.124">Koss-Harnes et al 2004</xref>, <xref ref-type="bibr" rid="eb-pa.REF.schara.2004.218">Schara et al 2004</xref>, <xref ref-type="bibr" rid="eb-pa.REF.pfendner.2005.241">Pfendner et al 2005</xref>]. Approximately 50 cases of EB-MD have been reported worldwide. Blistering occurs early and is generally mild. Muscular dystrophy may not appear until later childhood, adolescence, or in some cases adulthood, and can cause immobility and eventually death later in life. Some affected individuals develop cardiomyopathy [<xref ref-type="bibr" rid="eb-pa.REF.villa.2015.165">Villa et al 2015</xref>]. Pathogenic variants have been described throughout <italic toggle="yes">PLEC</italic> but appear to cluster in the two long open reading frames containing exons in the 3' end of the gene. Nonsense, missense, insertion/deletion, and splice junction variants have been described. The mildest phenotypes are usually associated with in-frame insertions or deletions, which do not alter the reading frame of the mRNA [<xref ref-type="bibr" rid="eb-pa.REF.pfendner.2005.241">Pfendner et al 2005</xref>]. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><bold>Limb-girdle muscular dystrophy type 2Q</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/613723">613723</ext-link>). This condition has been described in three Turkish families. Clinical features include proximal muscle weakness with onset in childhood and progression in puberty. Affected individuals were not reported to have any skin findings. The condition is inherited in an autosomal recessive manner. All affected individuals have been homozygous for a pathogenic 9-bp deletion in the alternately spliced and expressed exon1 (f) of plectin, which may be related to the expression of this isoform in different tissues [<xref ref-type="bibr" rid="eb-pa.REF.gundesli.2010.834">Gundesli et al 2010</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>EB</bold>
<bold>simplex</bold><bold>-Ogna</bold> (see <related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter">Epidermolysis Bullosa Simplex</related-object>), observed in one Norwegian and one German family with autosomal dominant inheritance, is a result of the site-specific missense p.Arg2110Trp variant within the rod domain of <italic toggle="yes">PLEC</italic> [<xref ref-type="bibr" rid="eb-pa.REF.kossharnes.2002.87">Koss-Harnes et al 2002</xref>]. A single lethal case of autosomal recessive EBS resulting from <italic toggle="yes">PLEC</italic> pathogenic variants has also been described [<xref ref-type="bibr" rid="eb-pa.REF.charlesworth.2003.1344">Charlesworth et al 2003</xref>]. <xref ref-type="bibr" rid="eb-pa.REF.kunz.2000.376">Kunz et al [2000]</xref> also described a case of EBS with severe mucous membrane involvement as a result of pathogenic variants in <italic toggle="yes">PLEC</italic>.</p>
          </list-item>
        </list>
      </sec>
      <sec id="eb-pa.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Pyloric atresia.</bold> In contrast to pyloric stenosis, which presents insidiously with vomiting, pyloric atresia is present at birth and causes complete obstruction of the gastric outlet. The diagnosis of epidermolysis bullosa with pyloric atresia (EB-PA) should be considered in every neonate with pyloric atresia regardless of the degree of skin blistering.</p>
        <p><bold>Epidermolysis bullosa (EB).</bold> According to the 2014 classification system, the four major types of EB, caused by pathogenic variants in 18 different genes, are EB simplex (EBS), junctional EB (JEB), dystrophic EB (DEB), and Kindler syndrome (KS) [<xref ref-type="bibr" rid="eb-pa.REF.fine.2014.1103">Fine et al 2014</xref>]. Classification into major type is based on the location of blistering in relation to the dermal-epidermal junction of skin. Subtypes are predominantly determined by clinical features and supported by molecular diagnosis.</p>
        <p>The four major types of EB share easy fragility of the skin (and mucosa in many cases), manifested by blistering with little or no trauma. Although clinical examination is useful in determining the extent of blistering and the presence of oral and other mucous membrane lesions, defining characteristics such as the presence and extent of scarring &#x02013; especially in young children and neonates &#x02012; may not be established or significant enough to allow identification of EB type; thus, molecular genetic testing (or less commonly skin biopsy) is usually required to establish the most precise diagnosis. The ability to induce blisters with friction (although the amount of friction can vary) and to enlarge blisters by applying pressure to the blister edge is common to all; mucosal and nail involvement and the presence or absence of milia may not be helpful discriminators.</p>
        <p>Post-inflammatory changes, such as those seen in generalized severe EBS (EBS-gen sev), are often mistaken for scarring or mottled pigmentation. Scarring can occur in simplex and junctional EB as a result of infection of erosions or scratching, which further damages the exposed surface. Congenital absence of the skin can be seen in any of the four major types of EB and is not a discriminating diagnostic feature.</p>
        <p>Corneal erosions, esophageal strictures, and nail involvement may indicate either DEB or JEB. In milder cases, scarring (especially of the dorsal hands and feet) suggests DEB. Pseudosyndactyly (mitten deformities) resulting from scarring of the hands and feet in older children and adults usually suggests DEB.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter"><bold>Epidermolysis bullosa simplex</bold></related-object>
<bold>(EBS)</bold> is characterized by fragility of the skin that results in nonscarring blisters caused by little or no trauma. The four most common clinical subtypes of EBS range from relatively mild blistering of the hands and feet to more generalized blistering, which can be fatal. Although EB-PA caused by biallelic pathogenic changes in <italic toggle="yes">PLEC</italic> is classified as a form of EBS, affected individuals are very rare compared to the overwhelming majority of individuals with EB caused by heterozygous (or rarely biallelic) pathogenic variants in <italic toggle="yes">KRT5</italic> or <italic toggle="yes">KRT14</italic>, which encode keratin 5 or 14, respectively. Therefore, the 2014 nomenclature refers to the specific pathogenic variants found in <italic toggle="yes">KRT5</italic> or <italic toggle="yes">KRT14</italic> (see Epidermolysis Bullosa Simplex: <related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter" object-id="ebs.Nomenclature" object-type="sec">Nomenclature</related-object>).</p>
        <list list-type="bullet">
          <list-item>
            <p>In <bold>EBS, localized</bold> (EBS-loc; previously known as Weber-Cockayne type), blisters are rarely present at birth and may occur on the knees and shins with crawling or on the feet at approximately age 18 months; some individuals manifest the disease in adolescence or early adulthood. Blisters are usually confined to the hands and feet, but can occur anywhere if trauma is significant.</p>
          </list-item>
          <list-item>
            <p>In <bold>EBS, generalized intermediate</bold> (<bold>EBS-gen intermed</bold>; previously known as Koebner type), blisters may be present at birth or develop within the first few months of life. Involvement is more widespread than in EBS-loc, but generally milder than in EBS-gen sev.</p>
          </list-item>
          <list-item>
            <p>In <bold>EBS with mottled pigmentation type (EBS-MP)</bold>, skin fragility is evident at birth and clinically indistinguishable from EBS-gen sev; over time, progressive brown pigmentation interspersed with depigmented spots develops on the trunk and extremities, the pigmentation disappearing in adult life. Focal palmar and plantar hyperkeratoses may occur.</p>
          </list-item>
          <list-item>
            <p>In <bold>EBS, generalized severe</bold> (<bold>EBS-gen sev</bold>; previously known as Dowling-Meara type), onset is usually at birth; severity varies greatly, both within and among families. Widespread and severe blistering and/or multiple grouped clumps of small blisters are typical and hemorrhagic blisters are common. Improvement occurs during mid- to late childhood. Progressive hyperkeratosis of the palms and soles begins in childhood and may be the major complaint of affected individuals in adult life. Nail dystrophy and milia are common. Both hyperpigmentation and hypopigmentation can occur. Mucosal involvement in EBS-gen sev may interfere with feeding. Blistering can be severe enough to result in neonatal or infant death.</p>
          </list-item>
        </list>
        <p><bold>EB caused by pathogenic variants in <italic toggle="yes">PLEC</italic>.</bold> Biallelic and heterozygous pathogenic variants in <italic toggle="yes">PLEC</italic>, the gene encoding plectin, which is located in the hemidesmosomes of the basement membrane zone of skin and muscle cells, cause cleavage in the basal keratinocyte layer. Hence, these disorders are classified as EBS in the 2014 classification system. In most cases, the associated phenotypes (i.e., EB with muscular dystrophy, EB with pyloric atresia) are more complex:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>EB with muscular dystrophy (EB-MD).</bold> See <xref ref-type="sec" rid="eb-pa.Genetically_Related_Allelic_Disord">Genetically Related Disorders</xref>.</p>
          </list-item>
          <list-item>
            <p><bold>EB with pyloric atresia (EB-PA)</bold> See <xref ref-type="sec" rid="eb-pa.Clinical_Characteristics">Clinical Characteristics</xref>.</p>
          </list-item>
          <list-item>
            <p><bold>EB-Ogna.</bold> See <xref ref-type="sec" rid="eb-pa.Genetically_Related_Allelic_Disord">Genetically Related Disorders</xref>.</p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="ebj" document-type="chapter"><bold>Junctional EB</bold></related-object>
<bold>(JEB)</bold> is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers, and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. The broad classification of JEB is divided into generalized and localized major subtypes with subordinate phenotypic subtypes. JEB, generalized includes: JEB, generalized severe (JEB-gen sev, formerly Herlitz JEB); JEB, generalized intermediate (JEB-gen intermed); JEB with pyloric atresia (JEB-PA); JEB-late onset (JEB-LO); and JEB with respiratory and renal involvement (JEB-RR).</p>
        <list list-type="bullet">
          <list-item>
            <p>In JEB-gen sev, the classic severe form of JEB, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur.</p>
          </list-item>
          <list-item>
            <p>In JEB-gen intermed, the phenotype may be milder with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period.</p>
          </list-item>
        </list>
        <p>Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, and joint contractures. Biallelic pathogenic variants in one of the following four genes are known to cause JEB: <italic toggle="yes">LAMB3</italic> (70% of all JEB), <italic toggle="yes">COL17A1</italic> (12%), <italic toggle="yes">LAMC2</italic> (9%), and <italic toggle="yes">LAMA3</italic> (9%).</p>
        <p>JEB with pyloric atresia has been associated with biallelic pathogenic variants in either &#x003b1;6&#x003b2;4 integrin or plectin; inheritance is autosomal recessive.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="ebd" document-type="chapter"><bold>Dystrophic EB</bold></related-object>
<bold>(DEB).</bold> The blister forms below the basement membrane, in the superficial dermis. The basement membrane is attached to the blister roof, resulting in scarring when blisters heal. Pathogenic variants in <italic toggle="yes">COL7A1</italic>, the gene encoding type VII collagen, have been demonstrated in all forms of DEB, both dominant and recessive [<xref ref-type="bibr" rid="eb-pa.REF.varki.2007.181">Varki et al 2007</xref>].</p>
      </sec>
      <sec id="eb-pa.Management">
        <title>Management</title>
        <sec id="eb-pa.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with epidermolysis bullosa with pyloric atresia (EB-PA), the following evaluations are recommended, if they were not performed as part of the evaluation that led to the diagnosis:</p>
          <list list-type="bullet">
            <list-item>
              <p>Evaluation of the sites of blister formation including skin and oral mucosa</p>
            </list-item>
            <list-item>
              <p>Tests of renal function including BUN, creatinine, and urinalysis</p>
            </list-item>
            <list-item>
              <p>Renal ultrasound</p>
            </list-item>
            <list-item>
              <p>Delineation of involvement of the whole esophagus (with concentration on the upper cervical portion) by barium swallow as needed. Endoscopy can be traumatic and should be avoided if possible.</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="eb-pa.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Skin.</bold> New blisters should be lanced and drained to prevent further spread from fluid pressure.</p>
          <p>In most cases, dressings for blisters involve three layers:</p>
          <list list-type="bullet">
            <list-item>
              <p>A primary nonadherent dressing that does not strip the top layers of the epidermis. Tolerance to different primary layers varies. Primary layers include the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Dressings impregnated with an emollient such as petrolatum or topical antiseptic (e.g., Vaseline<sup>&#x000ae;</sup> gauze, Adaptic<sup>&#x000ae;</sup>, Xeroform<sup>&#x000ae;</sup>)</p>
                </list-item>
                <list-item>
                  <p>Nonstick products (e.g., Telfa<sup>&#x000ae;</sup>, N-terface<sup>&#x000ae;</sup>)</p>
                </list-item>
                <list-item>
                  <p>Silicone-based products without adhesive (e.g., Mepitel<sup>&#x000ae;</sup>, Mepilex<sup>&#x000ae;</sup>)</p>
                </list-item>
                <list-item>
                  <p>Addition of a topical antibiotic or antiseptic such as bacitracin, mupirocin, silver, or honey</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>A secondary layer that provides stability for the primary layer and adds padding to allow more activity. Rolls of gauze (e.g., Kerlix<sup>&#x000ae;</sup> or Conform<sup>&#x000ae;</sup>) are commonly used.</p>
            </list-item>
            <list-item>
              <p>A tertiary layer that usually has some elastic properties and ensures the integrity of the dressing (e.g., Coban<sup>&#x000ae;</sup> or elasticized tube gauze of varying diameters such as Band Net<sup>&#x000ae;</sup> or Tubifast<sup>&#x000ae;</sup>).</p>
            </list-item>
          </list>
          <p>
            <bold>Gastrointestinal</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Surgical intervention is required to correct pyloric atresia. Many children need medical treatment for gastroesophageal reflux disease.</p>
            </list-item>
            <list-item>
              <p>Esophageal strictures and webs can be dilated repeatedly to improve swallowing [<xref ref-type="bibr" rid="eb-pa.REF.azizkhan.2007.801">Azizkhan et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p>Consultation with a dietitian or nutritionist can be helpful, especially if there is significant mucosal blistering in the mouth preventing adequate oral intake.</p>
            </list-item>
          </list>
          <p><bold>Renal.</bold> The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Referral to an urologist if there are symptoms of difficulty or discomfort with voiding</p>
            </list-item>
            <list-item>
              <p>Referral to a nephrologist if renal function studies and/or urinalysis are abnormal</p>
            </list-item>
          </list>
          <p>
            <bold>Other</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>A hoarse cry in an infant should alert the clinician to the possibility of airway obstruction with granulation tissue [<xref ref-type="bibr" rid="eb-pa.REF.ida.2012.657">Ida et al 2012</xref>]. Decisions about tracheostomy should involve the family and take into consideration the medical condition of the infant. Because of the poor prognosis and severe pain and discomfort experienced by these infants, a discussion with the family and hospital ethics committee often helps to determine the type of intervention and comfort care to provide [<xref ref-type="bibr" rid="eb-pa.REF.yan.2007.307">Yan et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p>Some children have delays or difficulty walking because of blistering and hyperkeratosis. Appropriate footwear and physical therapy are essential to preserve ambulation.</p>
            </list-item>
            <list-item>
              <p>Psychosocial support, including social services and psychological counseling, is essential [<xref ref-type="bibr" rid="eb-pa.REF.lucky.2007.809">Lucky et al 2007</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="eb-pa.Prevention_of_Primary_Manifestatio">
          <title>Prevention of Primary Manifestations</title>
          <p>New blister formation can be minimized by wrapping and padding of extremities; use of soft and properly fitted clothing and footwear; and avoidance of: contact with adhesives, contact sports, and other activities that create friction.</p>
        </sec>
        <sec id="eb-pa.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>The most common secondary complication is infection. In addition to wound care, treatment of chronic infection of wounds is a challenge. Many affected individuals become infected with resistant bacteria, most often methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> (MRSA), multidrug resistant <italic toggle="yes">Pseudomonas aeruginosa,</italic> and Group A beta-hemolytic <italic toggle="yes">Streptococci</italic>. Both antibiotics and antiseptics need to be employed.</p>
          <p>Fluid and electrolyte problems, which can be significant and even life threatening in the neonatal period and in infants with widespread disease, require careful management.</p>
          <p>Dilated cardiomyopathy can occur in individuals who survive the neonatal period. The development of dilated cardiomyopathy was associated with nutritional deficiency of carnitine in one study, and it has been postulated that nutritional deficiency of selenium may also contribute [<xref ref-type="bibr" rid="eb-pa.REF.sidwell.2000.59">Sidwell et al 2000</xref>].</p>
          <p>In children who survive the newborn period, nutritional deficiencies must also be addressed when they are identified:</p>
          <list list-type="bullet">
            <list-item>
              <p>Calcium and vitamin D replacement for osteopenia and osteoporosis</p>
            </list-item>
            <list-item>
              <p>Zinc supplementation for wound healing [<xref ref-type="bibr" rid="eb-pa.REF.mellerio.2007.795">Mellerio et al 2007</xref>]</p>
            </list-item>
            <list-item>
              <p>Selenium and carnitine replacement for possible prevention of dilated cardiomyopathy</p>
            </list-item>
          </list>
          <p>Iron deficiency anemia, a chronic problem, can be treated with oral or intravenous iron infusions and red blood cell transfusions.</p>
        </sec>
        <sec id="eb-pa.Surveillance">
          <title>Surveillance</title>
          <p>Perform annual screening for iron deficiency anemia with complete blood counts and possibly measurement of serum iron concentration to provide iron supplementation when necessary.</p>
          <p>Screen annually for zinc deficiency by measuring serum zinc concentration to provide zinc supplementation when necessary for enhanced wound healing.</p>
          <p>Periodic echocardiographic screening to evaluate for the development of dilated cardiomyopathy is appropriate.</p>
          <p>Screening with bone mineral density scanning may detect early osteopenia and/ or osteoporosis. No guidelines have been established regarding the age at which this should begin.</p>
        </sec>
        <sec id="eb-pa.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Most persons with EB-PA cannot use ordinary medical tape or Band-Aids<sup>&#x000ae;</sup>.</p>
          <p>Poorly fitting or coarse-textured clothing and footwear should be avoided as they can cause trauma.</p>
          <p>In general, activities that traumatize the skin (e.g., hiking, mountain biking, contact sports) should be avoided; affected individuals who are determined to participate in such activities should be encouraged to find creative ways to protect their skin.</p>
        </sec>
        <sec id="eb-pa.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="eb-pa.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="eb-pa.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Cesarean section is recommended by some obstetricians to reduce trauma to the skin of an affected fetus during delivery.</p>
        </sec>
        <sec id="eb-pa.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>See Junctional Epidermolysis Bullosa: <related-object link-type="booklink" source-id="gene" document-id="ebj" document-type="chapter" object-id="ebj.Therapies_Under_Investigation" object-type="sec">Management, Therapies Under Investigation</related-object>.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="eb-pa.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="eb-pa.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Epidermolysis bullosa with pyloric atresia (EB-PA) is inherited in an autosomal recessive manner.</p>
          <p>To date, there is no evidence to indicate that a heterozygous pathogenic variant in <italic toggle="yes">ITGA6</italic>, <italic toggle="yes">ITGB4</italic>, or <italic toggle="yes">PLEC</italic> results in EB-PA.</p>
        </sec>
        <sec id="eb-pa.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are usually obligate heterozygotes (i.e., carriers of one EB-PA-related pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Because germline mosaicism and uniparental isodisomy have been reported in EB-PA [<xref ref-type="bibr" rid="eb-pa.REF.natsuga.2010.2671">Natsuga et al 2010</xref>] and <related-object link-type="booklink" source-id="gene" document-id="ebj" document-type="chapter">JEB</related-object> [<xref ref-type="bibr" rid="eb-pa.REF.pulkkinen.1997a.611">Pulkkinen et al 1997a</xref>, <xref ref-type="bibr" rid="eb-pa.REF.takizawa.2000.307">Takizawa et al 2000</xref>, <xref ref-type="bibr" rid="eb-pa.REF.cserhalmifriedman.2002.468">Cserhalmi-Friedman et al 2002</xref>, <xref ref-type="bibr" rid="eb-pa.REF.fassihi.2005.71">Fassihi et al 2005</xref>, <xref ref-type="bibr" rid="eb-pa.REF.natsuga.2010.2671">Natsuga et al 2010</xref>], carrier status of parents needs to be confirmed with molecular genetic testing.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual whose parents are both carriers has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with EB-PA are obligate heterozygotes (carriers) for an <italic toggle="yes">ITGA6</italic>, <italic toggle="yes">ITGB4</italic>, or <italic toggle="yes">PLEC</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> Each sib of the proband's carrier parents is at a 50% risk of being a carrier of an <italic toggle="yes">ITGA6</italic>, <italic toggle="yes">ITGB4</italic>, or <italic toggle="yes">PLEC</italic> pathogenic variant.</p>
        </sec>
        <sec id="eb-pa.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the EB-PA-related pathogenic variants in the family.</p>
          <p>Sequencing of the entire gene in the unaffected reproductive partner of a known carrier is possible and is expected to identify more than 99% of pathogenic variants in that gene, as large deletions or insertions are extremely rare.</p>
        </sec>
        <sec id="eb-pa.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="eb-pa.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the <italic toggle="yes">ITGA6</italic>, <italic toggle="yes">ITGB4</italic>, or <italic toggle="yes">PLEC</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for EB-PA are possible.</p>
          <p><bold>Ultrasound examination.</bold> Occasionally pyloric atresia may be suspected because of oligohydramnios, with or without elevated concentration of alpha-fetoprotein and acetylcholinesterase, and echogenic material in the amniotic fluid [<xref ref-type="bibr" rid="eb-pa.REF.azarian.2006.57">Azarian et al 2006</xref>]. Gastric blockage may also be observed on fetal MRI [<xref ref-type="bibr" rid="eb-pa.REF.maurice.2013.908">Maurice et al 2013</xref>, <xref ref-type="bibr" rid="eb-pa.REF.merrow.2013.1656">Merrow et al 2013</xref>]. Complete chorioamniotic membrane separation detected through ultrasound can also be suggestive of the diagnosis of EB-PA [<xref ref-type="bibr" rid="eb-pa.REF.dural.2014.495">Dural et al 2014</xref>].</p>
        </sec>
      </sec>
      <sec id="eb-pa.Resources">
        <title>Resources</title>
      </sec>
      <sec id="eb-pa.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="eb-pa.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Integrins associate in pairs containing one alpha and one beta chain. The &#x003b1;6&#x003b2;4 integrin comprises one &#x003b1;6 (encoded by <italic toggle="yes">ITGA6</italic>) and one &#x003b2;4 integrin (encoded by <italic toggle="yes">ITGB4</italic>) from the integrin family of proteins, and is a component of the hemidesmosomes of the epidermis. Plectin is a large cytolinker protein expressed in the epidermis, muscle, and other tissues. Together, along with collagen XVII and CD151 (which are transmembrane proteins) and BP230, plectin and &#x003b1;6&#x003b2;4 integrin are critical structural components of the hemidesmosomes in the epidermis. The &#x003b1;6&#x003b2;4 integrin and plectin associate, causing a conformational change to a stable complex. This stabilization is thought to cause the recruitment of the other proteins into the hemidesmosomes. The &#x003b1;6&#x003b2;4 integrin also binds laminin 332 located in the basement membrane lamina lucida, and plectin binds the cytokeratins (as well as BP230), forming a continuous network of proteins that anchor the basement membrane complex to the cytokeratin layers of the epidermis. The result is a structurally resilient network of proteins binding the layers of the epidermis together [<xref ref-type="bibr" rid="eb-pa.REF.chung.2004.32287">Chung et al 2004</xref>, <xref ref-type="bibr" rid="eb-pa.REF.guo.2006.489">Guo et al 2006</xref>, <xref ref-type="bibr" rid="eb-pa.REF.yoon.2006.2732">Yoon et al 2006</xref>, <xref ref-type="bibr" rid="eb-pa.REF.folgiero.2007.1645">Folgiero et al 2007</xref>, <xref ref-type="bibr" rid="eb-pa.REF.de_pereda.2009.1180">de Pereda et al 2009</xref>].</p>
          <sec id="eb-pa.ITGA6">
            <title>
              <italic toggle="yes">ITGA6</italic>
            </title>
            <p><bold>Gene structure.</bold> Two transcript variants encoding two different isoforms have been reported. The cDNA of variant 1 comprises 5680 bp with an open reading frame of 3273 nucleotides encoding 1091 amino acids in 26 exons. Transcript variant 2 contains an alternate coding exon from variant 1 that results in a frameshift and is encoded in a 5810-bp cDNA. The resulting protein isoform b is shorter (1073 amino acids) than isoform a and has a distinct C terminus. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="eb-pa" object-id="eb-pa.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> Only six individuals with EB-PA caused by &#x003b1;6 integrin pathogenic variants have been described in the literature. Insertion/deletion, splice junction, and amino acid substitution variants have been described [<xref ref-type="bibr" rid="eb-pa.REF.ruzzi.1997.2826">Ruzzi et al 1997</xref>, <xref ref-type="bibr" rid="eb-pa.REF.gache.1998.914">Gache et al 1998</xref>, <xref ref-type="bibr" rid="eb-pa.REF.l_pinard.2000.70">L&#x000e9;pinard et al 2000</xref>, <xref ref-type="bibr" rid="eb-pa.REF.varki.2006.641">Varki et al 2006</xref>, <xref ref-type="bibr" rid="eb-pa.REF.masunaga.2017.160">Masunaga et al 2017</xref>].</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">ITGA6</italic> encodes integrin-&#x003b1;6, the alpha chain of &#x003b1;6&#x003b2;4 integrin.</p>
            <p><bold>Abnormal gene product.</bold> Loss or reduction of integrin-&#x003b1;6 results in disease.</p>
          </sec>
          <sec id="eb-pa.ITGB4">
            <title>
              <italic toggle="yes">ITGB4</italic>
            </title>
            <p><bold>Gene structure.</bold> The normal full-length cDNA is encoded in 41 exons spanning 36 kb of the genomic DNA. The cDNA comprises 5921 bp with an open reading frame of 5258 nucleotides encoding 1822 amino acids. Two splicing variants express different isoforms of the protein [<xref ref-type="bibr" rid="eb-pa.REF.pulkkinen.1997c.823">Pulkkinen et al 1997c</xref>]. The most common epidermal variant does not express exon 33. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="eb-pa" object-id="eb-pa.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> More than 100 pathogenic variants spanning all of <italic toggle="yes">ITGB4</italic> have been described in EB-PA [<xref ref-type="bibr" rid="eb-pa.REF.pulkkinen.1997b.669">Pulkkinen et al 1997b</xref>, <xref ref-type="bibr" rid="eb-pa.REF.pulkkinen.1997c.823">Pulkkinen et al 1997c</xref>, <xref ref-type="bibr" rid="eb-pa.REF.pulkkinen.1998a.935">Pulkkinen et al 1998a</xref>, <xref ref-type="bibr" rid="eb-pa.REF.pulkkinen.1998b.1376">Pulkkinen et al 1998b</xref>, <xref ref-type="bibr" rid="eb-pa.REF.ashton.2001.408">Ashton et al 2001</xref>, <xref ref-type="bibr" rid="eb-pa.REF.nakano.2001.618">Nakano et al 2001</xref>, <xref ref-type="bibr" rid="eb-pa.REF.iacovacci.2003.716">Iacovacci et al 2003</xref>, <xref ref-type="bibr" rid="eb-pa.REF.varki.2006.641">Varki et al 2006</xref>]. Pathogenic variants that cause premature termination codons on both alleles result in the most severe phenotypes, which are frequently lethal in the neonatal period. Other types of variants including amino acid substitutions and splicing variants may result in a less severe phenotype [<xref ref-type="bibr" rid="eb-pa.REF.mellerio.1998.862">Mellerio et al 1998</xref>, <xref ref-type="bibr" rid="eb-pa.REF.pulkkinen.1998b.1376">Pulkkinen et al 1998b</xref>, <xref ref-type="bibr" rid="eb-pa.REF.chavanas.1999.2097">Chavanas et al 1999</xref>, <xref ref-type="bibr" rid="eb-pa.REF.varki.2006.641">Varki et al 2006</xref>]. Rarely, homozygous variants associated with severe blistering without pyloric atresia have been described [<xref ref-type="bibr" rid="eb-pa.REF.inoue.2000.1061">Inoue et al 2000</xref>, <xref ref-type="bibr" rid="eb-pa.REF.jonkman.2000.227">Jonkman et al 2000</xref>]. Few recurrent pathogenic variants have been reported; however the variant p.Cys61Tyr is common in Hispanic persons with JEB-PA in the United States [<xref ref-type="bibr" rid="eb-pa.REF.varki.2006.641">Varki et al 2006</xref>]. Large deletions have also been described [<xref ref-type="bibr" rid="eb-pa.REF.menc_a.2016.269">Menc&#x000ed;a et al 2016</xref>].</p>
            <table-wrap id="eb-pa.T.selected_itgb4_pathogenic_varian" orientation="portrait" position="anchor">
              <label>Table 2. </label>
              <caption>
                <p>Selected <italic toggle="yes">ITGB4</italic> Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_eb-pa.T.selected_itgb4_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_eb-pa.T.selected_itgb4_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_eb-pa.T.selected_itgb4_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_eb-pa.T.selected_itgb4_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.182G&#x0003e;A</td>
                    <td headers="hd_h_eb-pa.T.selected_itgb4_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys61Tyr</td>
                    <td headers="hd_h_eb-pa.T.selected_itgb4_pathogenic_varian_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_000213.3">NM_000213.3</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_000204.3">NP_000204.3</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">ITGB4</italic> encodes integrin-&#x003b2;4, the alpha chain of &#x003b1;6&#x003b2;4 integrin.</p>
            <p><bold>Abnormal gene product.</bold> Loss or reduction of integrin-&#x003b2;4 results in disease.</p>
          </sec>
          <sec id="eb-pa.PLEC">
            <title>
              <italic toggle="yes">PLEC</italic>
            </title>
            <p><bold>Gene structure.</bold> The normal cDNA of variant 1 is 14755 bp with an open reading frame of 13722 nucleotides encoding 4575 amino acids in 32 exons [<xref ref-type="bibr" rid="eb-pa.REF.mclean.1996.1724">McLean et al 1996</xref>]. Expression of the different isoforms results from alternative splicing of exon 1 as well as use of different 5' untranslated regions. At least ten other variant transcripts have been described. The expression of different 5' regions affects the subcellular localization of the protein and the resulting attachments to organelles and intermediate filaments [<xref ref-type="bibr" rid="eb-pa.REF.rezniczek.2003.3181">Rezniczek et al 2003</xref>]. There is also a rodless form lacking exon 31. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="eb-pa" object-id="eb-pa.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic variants.</bold> All types of plectin variants causing EB-PA have been described: nonsense, missense, and splicing variants, insertions, and deletions [<xref ref-type="bibr" rid="eb-pa.REF.schara.2004.218">Schara et al 2004</xref>, <xref ref-type="bibr" rid="eb-pa.REF.nakamura.2005.28">Nakamura et al 2005</xref>, <xref ref-type="bibr" rid="eb-pa.REF.pfendner.2005.241">Pfendner et al 2005</xref>, <xref ref-type="bibr" rid="eb-pa.REF.uitto.2007.1995">Uitto et al 2007</xref>]. These variants have an autosomal recessive inheritance pattern and have been found throughout the gene, although clustering in the last two large exons has been observed. The mildest phenotypes are usually associated with amino acid substitutions or in-frame insertions or deletions [<xref ref-type="bibr" rid="eb-pa.REF.pfendner.2005.241">Pfendner et al 2005</xref>].</p>
            <p><bold>Normal gene product.</bold> Plectin links the intermediate filament network to the hemidesmosome and desmosomes (see <xref ref-type="sec" rid="eb-pa.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>). At least 11 different isoforms are produced by alternative splicing and use of different 5' untranslated regions [<xref ref-type="bibr" rid="eb-pa.REF.rezniczek.2003.3181">Rezniczek et al 2003</xref>].</p>
            <p><bold>Abnormal gene product.</bold> Loss or reduction of plectin results in disease.</p>
          </sec>
        </sec>
      </sec>
      <sec id="eb-pa.References">
        <title>References</title>
        <sec id="eb-pa.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="eb-pa.Literature_Cited.reflist0">
            <ref id="eb-pa.REF.ashton.2001.408">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorelli</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keane</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Alpha 6 beta 4 integrin abnormalities in junctional epidermolysis bullosa with pyloric atresia.</article-title>
                <source>Br J Dermatol</source>
                <volume>144</volume>
                <fpage>408</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">11251584</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.azarian.2006.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Azarian</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dreux</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vuillard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haber</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guimiot</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Prenatal diagnosis of inherited epidermolysis bullosa in a patient with no family history: a case report and literature review.</article-title>
                <source>Prenat Diagn</source>
                <volume>26</volume>
                <fpage>57</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16378325</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.azizkhan.2007.801">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Azizkhan</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denyer</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacigalupo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kantor</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passalacqua</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palisson</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Surgical management of epidermolysis bullosa: Proceedings of the Second International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005.</article-title>
                <source>Int J Dermatol</source>
                <volume>46</volume>
                <fpage>801</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17651160</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.birnbaum.2008.1063">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Birnbaum</surname>
                    <given-names>RY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elbedour</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ofir</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birk</surname>
                    <given-names>OS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carmi</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Deletion of the first pair of fibronectin type III repeats of the integrin beta-4 gene is associated with epidermolysis bullosa, pyloric atresia and aplasia cutis congenita in the original Carmi syndrome patients.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2008</year>
                <volume>146A</volume>
                <fpage>1063</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18348258</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.charlesworth.2003.1344">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Charlesworth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gagnoux-Palacios</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonduelle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortonne</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Raeve</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Identification of a lethal form of epidermolysis bullosa simplex associated with a homozygous genetic mutation in plectin.</article-title>
                <source>J Invest Dermatol</source>
                <volume>121</volume>
                <fpage>1344</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14675180</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.chavanas.1999.2097">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chavanas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gache</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vailly</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanitakis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortonne</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Splicing modulation of integrin beta4 pre-mRNA carrying a branch point mutation underlies epidermolysis bullosa with pyloric atresia undergoing spontaneous amelioration with ageing.</article-title>
                <source>Hum Mol Genet</source>
                <volume>8</volume>
                <fpage>2097</fpage>
                <lpage>105</lpage>
                <pub-id pub-id-type="pmid">10484780</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.chung.2004.32287">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>SO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipscomb</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercurio</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The Met receptor and alpha 6 beta 4 integrin can function independently to promote carcinoma invasion.</article-title>
                <source>J Biol Chem</source>
                <volume>279</volume>
                <fpage>32287</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">15161909</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.cserhalmifriedman.2002.468">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cserhalmi-Friedman</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anyane-Yeboa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiano</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Paternal germline mosaicism in Herlitz junctional epidermolysis bullosa.</article-title>
                <source>Exp Dermatol</source>
                <volume>11</volume>
                <fpage>468</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">12366701</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.de_pereda.2009.1180">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Pereda</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lillo</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sonnenberg</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Structural basis of the interaction between integrin alpha6beta4 and plectin at the hemidesmosomes.</article-title>
                <source>EMBO J.</source>
                <year>2009</year>
                <volume>28</volume>
                <fpage>1180</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">19242489</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.dural.2014.495">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dural</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acar</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ekiz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aslan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polat</surname>
                    <given-names>&#x00130;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yildirim</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gulac</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erdemoglu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cay</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hac&#x00131;hasanoglu</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal ultrasound findings and a new ultrasonographic sign of epidermolysis bullosa with congenital pyloric atresia: a report of three cases.</article-title>
                <source>J Med Ultrason.</source>
                <year>2014</year>
                <volume>41</volume>
                <fpage>495</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">27278032</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.fassihi.2005.71">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fassihi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessagowit</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashton</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denyer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Complete paternal uniparental isodisomy of chromosome 1 resulting in Herlitz junctional epidermolysis bullosa.</article-title>
                <source>Clin Exp Dermatol</source>
                <volume>30</volume>
                <fpage>71</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15663509</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.fine.1999">
              <mixed-citation publication-type="book">Fine JD, Bauer EA, McGuire J, Moshell A. <italic toggle="yes">Epidermolysis Bullosa: Clinical, Epidemiologic, and Laboratory Advances, and the Findings of the National Epidermolysis Bullosa Registry</italic>. Baltimore, MD: Johns Hopkins University Press; 1999.</mixed-citation>
            </ref>
            <ref id="eb-pa.REF.fine.2014.1103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fine</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Has</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heagerty</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hintner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hovnanian</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leigh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marinkovich</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodley</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambruno</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification.</article-title>
                <source>J Am Acad Dermatol</source>
                <year>2014</year>
                <volume>70</volume>
                <fpage>1103</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">24690439</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.folgiero.2007.1645">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Folgiero</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bachelder</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bon</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falcioni</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercurio</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The alpha6beta4 integrin can regulate ErbB-3 expression: implications for alpha6beta4 signaling and function.</article-title>
                <source>Cancer Res</source>
                <volume>67</volume>
                <fpage>1645</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">17308105</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.gache.1998.914">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gache</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero-Graillet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spadafora</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000e9;pinard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Descamps</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardon</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortonne</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>A novel homozygous mutation affecting integrin alpha6 in a case of junctional epidermolysis bullosa with pyloric atresia detected in utero by ultrasound examination.</article-title>
                <source>J Invest Dermatol</source>
                <volume>111</volume>
                <fpage>914</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9804362</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.gundesli.2010.834">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gundesli</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talim</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korkusuz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balci-Hayta</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cirak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akarsu</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topaloglu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dincer</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Mutation in exon 1f of PLEC, leading to disruption of plectin isoform 1f, causes autosomal-recessive limb-girdle muscular dystrophy.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2010</year>
                <volume>87</volume>
                <fpage>834</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">21109228</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.guo.2006.489">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pylayeva</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pepe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshioka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inghirami</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giancotti</surname>
                    <given-names>FG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.</article-title>
                <source>Cell</source>
                <volume>126</volume>
                <fpage>489</fpage>
                <lpage>502</lpage>
                <pub-id pub-id-type="pmid">16901783</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.iacovacci.2003.716">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iacovacci</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cicuzza</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odorisio</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvestri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayserili</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambruno</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puddu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Alessio</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Novel and recurrent mutations in the integrin beta 4 subunit gene causing lethal junctional epidermolysis bullosa with pyloric atresia.</article-title>
                <source>Exp Dermatol</source>
                <volume>12</volume>
                <fpage>716</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">14705814</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.ida.2012.657">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ida</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Livshitz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azizkhan</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elluru</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <article-title>Upper airway complications of junctional epidermolysis bullosa.</article-title>
                <source>J Pediatr.</source>
                <year>2012</year>
                <volume>160</volume>
                <fpage>657</fpage>
                <lpage>61.e1</lpage>
                <pub-id pub-id-type="pmid">22050875</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.inoue.2000.1061">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owaribe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A homozygous missense mutation in the cytoplasmic tail of beta4 integrin, G931D, that disrupts hemidesmosome assembly and underlies Non-Herlitz junctional epidermolysis bullosa without pyloric atresia?</article-title>
                <source>J Invest Dermatol</source>
                <volume>114</volume>
                <fpage>1061</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10792571</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.jonkman.2002.1275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijenhuis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kloosterhuis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steege</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Deletion of a cytoplasmic domain of integrin beta4 causes epidermolysis bullosa simplex.</article-title>
                <source>J Invest Dermatol</source>
                <volume>119</volume>
                <fpage>1275</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">12485428</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.jonkman.2000.227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuur</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dijk</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heeres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Jong</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Meer</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yancey</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3.</article-title>
                <source>Arch Dermatol</source>
                <volume>136</volume>
                <fpage>227</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">10677099</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.kambham.2000.190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kambham</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanji</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seigle</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markowitz</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Agati</surname>
                    <given-names>VD</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Congenital focal segmental glomerulosclerosis associated with beta4 integrin mutation and epidermolysis bullosa.</article-title>
                <source>Am J Kidney Dis</source>
                <volume>36</volume>
                <fpage>190</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10873890</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.kossharnes.2002.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koss-Harnes</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyheim</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anton-Lamprecht</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gjesti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jorgensen</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jahnsen</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olaisen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiche</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gedde-Dahl</surname>
                    <given-names>T</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations.</article-title>
                <source>J Invest Dermatol</source>
                <volume>118</volume>
                <fpage>87</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">11851880</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.kossharnes.2004.124">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koss-Harnes</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyheim</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Groot</surname>
                    <given-names>WP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Weerdt</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikolic</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiche</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gedde-Dahl</surname>
                    <given-names>T</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Life-long course and molecular characterization of the original Dutch family with epidermolysis bullosa simplex with muscular dystrophy due to a homozygous novel plectin point mutation.</article-title>
                <source>Acta Derm Venereol</source>
                <volume>84</volume>
                <fpage>124</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15206692</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.kunz.2000.376">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kunz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamm</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeschke</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brocker</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiche</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zillikens</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutation reports: epidermolysis bullosa simplex associated with severe mucous membrane involvement and novel mutations in the plectin gene.</article-title>
                <source>J Invest Dermatol</source>
                <volume>114</volume>
                <fpage>376</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">10652001</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.l_pinard.2000.70">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L&#x000e9;pinard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Descamps</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanchet-Bardon</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Germain</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larget-Piet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beringue</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berchel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dumez</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Prenatal diagnosis of pyloric atresia-junctional epidermolysis bullosa syndrome in a fetus not known to be at risk.</article-title>
                <source>Prenat Diagn</source>
                <volume>20</volume>
                <fpage>70</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10701857</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.lucky.2007.809">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pillay</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paskel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palisson</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Psychosocial aspects of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005.</article-title>
                <source>Int J Dermatol</source>
                <volume>46</volume>
                <fpage>809</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">17651161</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.masunaga.2015.61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Masunaga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niizeki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasuda</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amagai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiko</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Splicing abnormality of integrin &#x003b2;4 gene (ITGB4) due to nucleotide substitutions far from splice site underlies pyloric atresia-junctional epidermolysis bullosa syndrome.</article-title>
                <source>J Dermatol Sci.</source>
                <year>2015</year>
                <volume>78</volume>
                <fpage>61</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">25728941</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.masunaga.2017.160">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Masunaga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishikawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiko</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Compound heterozygosity for novel splice site mutations of ITGA6 in lethal junctional epidermolysis bullosa with pyloric atresia.</article-title>
                <source>J Dermatol.</source>
                <year>2017</year>
                <volume>44</volume>
                <fpage>160</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">27607025</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.maurice.2013.908">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maurice</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eyrolle-Guignot</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dhombres</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzales</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jouannic</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>The key role of ultrasound examination in the prenatal diagnosis of epidermolysis bullosa with pyloric atresia.</article-title>
                <source>Prenat Diagn.</source>
                <year>2013</year>
                <volume>33</volume>
                <fpage>908</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23613220</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.mclean.1996.1724">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rugg</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bullrich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgeson</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owaribe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMillan</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leigh</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christiano</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization.</article-title>
                <source>Genes Dev</source>
                <volume>10</volume>
                <fpage>1724</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">8698233</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.mellerio.1998.862">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMillan</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lake</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horn</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tidman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eady</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Pyloric atresia-junctional epidermolysis bullosa syndrome: mutations in the integrin beta4 gene (ITGB4) in two unrelated patients with mild disease.</article-title>
                <source>Br J Dermatol</source>
                <volume>139</volume>
                <fpage>862</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">9892956</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.mellerio.2007.795">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denyer</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pillay</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palisson</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Medical management of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005.</article-title>
                <source>Int J Dermatol</source>
                <volume>46</volume>
                <fpage>795</fpage>
                <lpage>800</lpage>
                <pub-id pub-id-type="pmid">17651159</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.menc_a.2016.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Menc&#x000ed;a</surname>
                    <given-names>&#x000c1;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Llames</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charlesworth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lucas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vicente</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trujillo-Tiebas</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coto</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vera</surname>
                    <given-names>&#x000c1;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez-Pesta&#x000f1;a</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murillas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jorcano</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conti</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esc&#x000e1;mez Toledano</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>del R&#x000ed;o Nechaevsky</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Identification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresia.</article-title>
                <source>Exp Dermatol.</source>
                <year>2016</year>
                <volume>25</volume>
                <fpage>269</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">26739954</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.merrow.2013.1656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Merrow</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frischer</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                </person-group>
                <article-title>Pyloric atresia with epidermolysis bullosa: fetal MRI diagnosis with postnatal correlation.</article-title>
                <source>Pediatr Radiol.</source>
                <year>2013</year>
                <volume>43</volume>
                <fpage>1656</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">23832020</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.mutlu.2015.385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mutlu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalay</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dilber</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aslan</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dilber</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almaani</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Pyloric atresia-junctional epidermolysis bullosa syndrome showing novel c.4505-4508insACTC mutations in integrin b4 gene (ITGB4).</article-title>
                <source>Turk J Pediatr.</source>
                <year>2015</year>
                <volume>57</volume>
                <fpage>385</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">27186702</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.nakamura.2005.28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMillan</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kono</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paku</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogiso</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Epidermolysis bullosa simplex associated with pyloric atresia is a novel clinical subtype caused by mutations in the plectin gene (PLEC).</article-title>
                <source>J Mol Diagn</source>
                <volume>7</volume>
                <fpage>28</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">15681471</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.nakano.2001.618">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rico</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garzon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Epidermolysis bullosa with congenital pyloric atresia: novel mutations in the beta 4 integrin gene (ITGB4) and genotype/phenotype correlations.</article-title>
                <source>Pediatr Res</source>
                <volume>49</volume>
                <fpage>618</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">11328943</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.nakano.2000.493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Herlitz junctional epidermolysis bullosa: novel and recurrent mutations in the LAMB3 gene and the population carrier frequency.</article-title>
                <source>J Invest Dermatol</source>
                <volume>115</volume>
                <fpage>493</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11023379</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.natsuga.2010.2671">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Natsuga</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishie</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arita</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinkuma</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubota</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imakado</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Complete paternal isodisomy of chromosome 17 in junctional epidermolysis bullosa with pyloric atresia.</article-title>
                <source>J Invest Dermatol.</source>
                <volume>130</volume>
                <fpage>2671</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20596088</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.pasmooij.2004.669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasmooij</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Steege</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pas</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smitt</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijenhuis</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuiderveen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonkman</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen.</article-title>
                <source>Br J Dermatol</source>
                <volume>151</volume>
                <fpage>669</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">15377356</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.pfendner.2005.241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Progress in epidermolysis bullosa: the phenotypic spectrum of plectin mutations.</article-title>
                <source>Exp Dermatol</source>
                <volume>14</volume>
                <fpage>241</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15810881</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.pfendner.2007.781">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conget</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palisson</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Basic science of epidermolysis bullosa and diagnostic and molecular characterization: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005.</article-title>
                <source>Int J Dermatol</source>
                <volume>46</volume>
                <fpage>781</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">17651158</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.pulkkinen.1998a.935">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>August</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1998a</year>
                <article-title>Compound heterozygosity for missense (L156P) and nonsense (R554X) mutations in the beta4 integrin gene (ITGB4) underlies mild, nonlethal phenotype of epidermolysis bullosa with pyloric atresia.</article-title>
                <source>Am J Pathol</source>
                <volume>152</volume>
                <fpage>935</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">9546354</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.pulkkinen.1997a.611">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bullrich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czarnecki</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1997a</year>
                <article-title>Maternal uniparental disomy of chromosome 1 with reduction to homozygosity of the LAMB3 locus in a patient with Herlitz junctional epidermolysis bullosa.</article-title>
                <source>Am J Hum Genet</source>
                <volume>61</volume>
                <fpage>611</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9326326</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.pulkkinen.1997b.669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spanou</surname>
                    <given-names>EN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1997b</year>
                <article-title>Homozygous alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia.</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>669</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">9158140</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.pulkkinen.1997c.823">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurtz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1997c</year>
                <article-title>Genomic organization of the integrin beta 4 gene (ITGB4): a homozygous splice-site mutation in a patient with junctional epidermolysis bullosa associated with pyloric atresia.</article-title>
                <source>Lab Invest</source>
                <volume>76</volume>
                <fpage>823</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">9194858</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.pulkkinen.1998b.1376">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallerstein</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garzon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1998b</year>
                <article-title>Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense.</article-title>
                <source>Am J Hum Genet</source>
                <volume>63</volume>
                <fpage>1376</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">9792864</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.puvabanditsin.1997.359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Puvabanditsin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrow</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samransamraujkit</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>WC</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Epidermolysis bullosa associated with congenital localized absence of skin, fetal abdominal mass, and pyloric atresia.</article-title>
                <source>Pediatr Dermatol</source>
                <volume>14</volume>
                <fpage>359</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">9336805</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.rezniczek.2003.3181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rezniczek</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abrahamsberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuchs</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spazierer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiche</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Plectin 5'-transcript diversity: short alternative sequences determine stability of gene products, initiation of translation and subcellular localization of isoforms.</article-title>
                <source>Hum Mol Genet</source>
                <volume>12</volume>
                <fpage>3181</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">14559777</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.ruzzi.1997.2826">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ruzzi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gagnoux-Palacios</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinola</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneguzzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Alessio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zambruno</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia.</article-title>
                <source>J Clin Invest</source>
                <volume>99</volume>
                <fpage>2826</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">9185503</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.salvestrini.2008.585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Salvestrini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozoemena</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Husain</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buhamrah</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabery</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leichtner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rufo</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez-Atayde</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orteu</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torrente</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heuschkel</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murch</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Desquamative enteropathy and pyloric atresia without skin disease caused by a novel intracellular beta4 integrin mutation.</article-title>
                <source>J Pediatr Gastroenterol Nutr.</source>
                <volume>47</volume>
                <fpage>585</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">18955862</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.schara.2004.218">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nusslein</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zillikens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner-Tuderman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiche</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroder</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Severe mucous membrane involvement in epidermolysis bullosa simplex with muscular dystrophy due to a novel plectin gene mutation.</article-title>
                <source>Eur J Pediatr</source>
                <volume>163</volume>
                <fpage>218</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">14963703</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.sidwell.2000.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sidwell</surname>
                    <given-names>RU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yates</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Dilated cardiomyopathy in dystrophic epidermolysis bullosa.</article-title>
                <source>Arch Dis Child.</source>
                <year>2000</year>
                <volume>83</volume>
                <fpage>59</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">10869001</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.takizawa.2000.307">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takizawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chao</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakajima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutation report: complete paternal uniparental isodisomy of chromosome 1: a novel mechanism for Herlitz junctional epidermolysis bullosa.</article-title>
                <source>J Invest Dermatol</source>
                <volume>115</volume>
                <fpage>307</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">10951251</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.uitto.2007.1995">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Diseases of epidermal keratins and their linker proteins.</article-title>
                <source>Exp Cell Res</source>
                <volume>313</volume>
                <fpage>1995</fpage>
                <lpage>2009</lpage>
                <pub-id pub-id-type="pmid">17531221</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.varki.2006.641">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Varki</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadowski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants.</article-title>
                <source>J Med Genet</source>
                <volume>43</volume>
                <fpage>641</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">16473856</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.varki.2007.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Varki</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadowski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfendner</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes.</article-title>
                <source>J Med Genet</source>
                <volume>44</volume>
                <fpage>181</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">16971478</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.villa.2015.165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryan</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucky</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jefferies</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>Left ventricular non-compaction cardiomyopathy associated with epidermolysis bullosa simplex with muscular dystrophy and PLEC mutation.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2015</year>
                <volume>25</volume>
                <fpage>165</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25454730</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.walker.2017.e61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woody</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orrin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellerio</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <article-title>Epidermolysis bullosa with pyloric atresia and significant urologic involvement.</article-title>
                <source>Pediatr Dermatol.</source>
                <year>2017</year>
                <volume>34</volume>
                <fpage>e61</fpage>
                <lpage>e64</lpage>
                <pub-id pub-id-type="pmid">27813154</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.wallerstein.2000.286">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wallerstein</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genieser</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulkkinen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Epidermolysis bullosa, pyloric atresia, and obstructive uropathy: a report of two case reports with molecular correlation and clinical management.</article-title>
                <source>Pediatr Dermatol</source>
                <volume>17</volume>
                <fpage>286</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10990577</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.yan.2007.307">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paris</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahluwalia</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruckner</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Treatment decision-making for patients with the Herlitz subtype of junctional epidermolysis bullosa.</article-title>
                <source>J Perinatol</source>
                <volume>27</volume>
                <fpage>307</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">17363907</pub-id>
              </element-citation>
            </ref>
            <ref id="eb-pa.REF.yoon.2006.2732">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>SO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipscomb</surname>
                    <given-names>EA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling.</article-title>
                <source>Cancer Res</source>
                <volume>66</volume>
                <fpage>2732</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16510594</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="eb-pa.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="eb-pa.Author_Notes">
          <title>Author Notes</title>
          <p>Web: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.genedx.com/">www.genedx.com</ext-link></p>
          <p>Web: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cincinnatichildrens.org/eb-center">www.cincinnatichildrens.org/eb-center</ext-link></p>
        </sec>
        <sec id="eb-pa.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>7 September 2017 (ma) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>14 February 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>28 April 2009 (cd) Revision: <italic toggle="yes">PLEC</italic> testing clinically available; prenatal testing available</p>
            </list-item>
            <list-item>
              <p>22 February 2008 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>10 May 2007 (egp) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="eb-pa.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Radiograph of a 36-week gestational-age, one-day-old neonate with EB-PA. Note the single gastric bubble (white arrow).</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="eb-pa-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
